Related references
Note: Only part of the references are listed.Clinical Effects of the Self-administered Subcutaneous Complement Inhibitor Zilucoplan in Patients With Moderate to Severe Generalized Myasthenia Gravis Results of a Phase 2 Randomized, Double-Blind, Placebo-Controlled, Multicenter Clinical Trial
James F. Howard et al.
JAMA NEUROLOGY (2020)
Immune-mediated necrotizing myopathy: clinical features and pathogenesis
Yves Allenbach et al.
NATURE REVIEWS RHEUMATOLOGY (2020)
Eculizumab in Aquaporin-4-Positive Neuromyelitis Optica Spectrum Disorder
S. J. Pittock et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
In vivo pathogenicity of IgG from patients with anti-SRP or anti-HMGCR autoantibodies in immune-mediated necrotising myopathy
Cecile Bergua et al.
ANNALS OF THE RHEUMATIC DISEASES (2019)
Necrosis in anti-SRP+ and anti-HMGCR+myopathies: Role of autoantibodies and complement
Yves Allenbach et al.
NEUROLOGY (2018)
224th ENMC International Workshop: Clinico-sero-pathological classification of immune-mediated necrotizing myopathies Zandvoort, The Netherlands, 14-16 October 2016
Yves Allenbach et al.
NEUROMUSCULAR DISORDERS (2018)
Systemic lupus erythematosus: state of the art on clinical practice guidelines
Farah Tamirou et al.
RMD OPEN (2018)
Longitudinal Course of Disease in a Large Cohort of Myositis Patients With Autoantibodies Recognizing the Signal Recognition Particle
Iago Pinal-Fernandez et al.
ARTHRITIS CARE & RESEARCH (2017)
Pathogenic Role of Anti-Signal Recognition Protein and Anti-3-Hydroxy-3-Methylglutaryl-CoA Reductase Antibodies in Necrotizing Myopathies: Myofiber Atrophy and Impairment of Muscle Regeneration in Necrotizing Autoimmune Myopathies
Louiza Arouche-Delaperche et al.
ANNALS OF NEUROLOGY (2017)
Clinical features and prognosis in anti-SRP and anti-HMGCR necrotising myopathy
Yurika Watanabe et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2016)
Eculizumab as rescue therapy in severe resistant lupus nephritis
Matthew C. Pickering et al.
RHEUMATOLOGY (2015)
Exploring necrotizing autoimmune myopathies with a novel immunoassay for anti-3-hydroxy-3-methyl-glutaryl-CoA reductase autoantibodies
Laurent Drouot et al.
ARTHRITIS RESEARCH & THERAPY (2014)
Antibody Levels Correlate With Creatine Kinase Levels and Strength in Anti-3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase-Associated Autoimmune Myopathy
Jessie L. Werner et al.
ARTHRITIS AND RHEUMATISM (2012)
Autoantibodies Against 3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase in Patients With Statin-Associated Autoimmune Myopathy
Andrew L. Mammen et al.
ARTHRITIS AND RHEUMATISM (2011)
Correlation of Anti-Signal Recognition Particle Autoantibody Levels With Creatine Kinase Activity in Patients With Necrotizing Myopathy
Olivier Benveniste et al.
ARTHRITIS AND RHEUMATISM (2011)
A Novel Autoantibody Recognizing 200-kd and 100-kd Proteins Is Associated With an Immune-Mediated Necrotizing Myopathy
Lisa Christopher-Stine et al.
ARTHRITIS AND RHEUMATISM (2010)
Share Paper
